{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:51:28Z","timestamp":1766559088234,"version":"3.48.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Italian Ministry of University and Research"},{"DOI":"10.13039\/501100012305","name":"Universit\u00e0 degli Studi del Molise","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012305","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is a neurodegenerative disorder that is characterized by \u03b1-synuclein aggregation, mitochondrial dysfunction, and impaired proteostasis. The peripheral biomarkers that reflect these cellular perturbations remain incompletely defined. This study aimed to evaluate the enzymatic activity and gene expression of two key protein degradation enzymes, Acyl PEptide Hydrolase (APEH) and Proteasome Subunit Beta Type-5 (PSMB5), in the peripheral blood of PD patients and to relate these findings to the severity of the disease. Thirteen PD patients and 13 age-matched healthy controls (HLT) were recruited. APEH and PSMB5 chymotrypsin-like (CT-like) activity were measured in whole blood, erythrocytes and immune cell fractions. Gene expression analysis was performed for\n                    <jats:italic>APEH<\/jats:italic>\n                    and\n                    <jats:italic>PSMB5<\/jats:italic>\n                    and their related genes, plus other genes typical of parkinsonism or indicative of metabolic alterations: N(alpha)-acetyltransferase (\n                    <jats:italic>NAA10<\/jats:italic>\n                    ) Aminoacylase 1 (\n                    <jats:italic>ACY1<\/jats:italic>\n                    ), Ubiquitin-activating enzyme 1 (\n                    <jats:italic>UBA1<\/jats:italic>\n                    ), Ubiquitin conjugating enzyme E2 I (\n                    <jats:italic>UBE2I<\/jats:italic>\n                    ), Parkin RBR E3 ubiquitin protein ligase (\n                    <jats:italic>PRKN<\/jats:italic>\n                    ), Alpha-synuclein (\n                    <jats:italic>SNCA<\/jats:italic>\n                    ), Parkinsonism associated deglycase DJ-1 (\n                    <jats:italic>PARK7<\/jats:italic>\n                    ), and mitochondrial Mn-SOD (\n                    <jats:italic>SOD2<\/jats:italic>\n                    ). APEH activity did not differ significantly between PD and HLT in whole blood cells or cellular fractions. Conversely, PSMB5 CT-like activity was reduced in lymphocytes from PD patients, whereas erythrocytes and whole blood exhibited elevated activity. No changes in\n                    <jats:italic>APEH<\/jats:italic>\n                    and\n                    <jats:italic>PSMB5<\/jats:italic>\n                    expression were observed, while\n                    <jats:italic>PARK7<\/jats:italic>\n                    significantly decreased in patients with PD. Correlation analysis showed that proteasomal changes correlated with disease severity, and cognitive impairment. Our findings revealed compartment-specific proteasomal dysregulation in the peripheral blood of PD patients, suggesting systemic proteostasis imbalance. These alterations appeared more pronounced in patients with more severe clinical progression. This study supports the potential of peripheral proteasomal activity profiles as biomarkers linked to PD progression, warranting further investigation in larger cohorts.\n                  <\/jats:p>","DOI":"10.1007\/s12035-025-05624-8","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:34:27Z","timestamp":1766547267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteasome Dysregulation in Parkinson\u2019s Disease: Insights from Blood-Based Analyses"],"prefix":"10.1007","volume":"63","author":[{"given":"Alfonso","family":"Di Costanzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Camerlingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Min\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Tiberio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Matrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Cocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"4","key":"5624_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/cimb47040259","volume":"47","author":"N Brezic","year":"2025","unstructured":"Brezic N, Gligorevic S, Sic A, Knezevic NN (2025) Protein misfolding and aggregation as a mechanistic link between chronic pain and neurodegenerative diseases. Curr Issues Mol Biol 47(4):259","journal-title":"Curr Issues Mol Biol"},{"issue":"21","key":"5624_CR2","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.3390\/ijms20215312","volume":"20","author":"K-J Lin","year":"2019","unstructured":"Lin K-J, Lin K-L, Chen S-D, Liou C-W, Chuang Y-C, Lin H-Y, Lin T-K (2019) The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson\u2019s disease. Int J Mol Sci 20(21):5312","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5624_CR3","first-page":"2695","volume":"16","author":"SK Soman","year":"2025","unstructured":"Soman SK, Woodruff MR, Dagda RK (2025) The mitochondrial foundations of Parkinson\u2019s disease: therapeutic implications. Aging Dis 16(5):2695","journal-title":"Aging Dis"},{"issue":"6","key":"5624_CR4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/med.21502","volume":"38","author":"R Mishra","year":"2018","unstructured":"Mishra R, Upadhyay A, Prajapati VK, Mishra A (2018) Proteasome-mediated proteostasis: novel medicinal and pharmacological strategies for diseases. Med Res Rev 38(6):1916\u20131973","journal-title":"Med Res Rev"},{"key":"5624_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","volume":"50","author":"S-L Paiva","year":"2019","unstructured":"Paiva S-L, Crews CM (2019) Targeted protein degradation: elements of PROTAC design. Curr Opin Chem Biol 50:111\u2013119","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"5624_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41467-018-08027-7","volume":"10","author":"BE Smith","year":"2019","unstructured":"Smith BE, Wang SL, Jaime-Figueroa S, Harbin A, Wang J, Hamman BD, Crews CM (2019) Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat Commun 10(1):131","journal-title":"Nat Commun"},{"issue":"2","key":"5624_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41419-021-03441-0","volume":"12","author":"M Bi","year":"2021","unstructured":"Bi M, Du X, Jiao Q, Chen X, Jiang H (2021) Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown. Cell Death Dis 12(2):154","journal-title":"Cell Death Dis"},{"issue":"22","key":"5624_CR8","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/1873-3468.14479","volume":"596","author":"HJ Jang","year":"2022","unstructured":"Jang HJ, Chung KC (2022) The ubiquitin\u2013proteasome system and autophagy mutually interact in neurotoxin-induced dopaminergic cell death models of Parkinson\u2019s disease. FEBS Lett 596(22):2898\u20132913","journal-title":"FEBS Lett"},{"issue":"1","key":"5624_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E, Neudorfer C, Chau H, Ngana SG, O\u2019Hara DM, Brotchie JM, et al (2020) Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein. Acta Neuropathol Commun 8(1):17","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"5624_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2020.09.007","volume":"52","author":"I Fernandez-Cruz","year":"2021","unstructured":"Fernandez-Cruz I, Reynaud E (2021) Proteasome subunits involved in neurodegenerative diseases. Arch Med Res 52(1):1\u201314","journal-title":"Arch Med Res"},{"issue":"3","key":"5624_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3233\/JAD-170389","volume":"60","author":"G Palmieri","year":"2017","unstructured":"Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, et al (2017) Low erythrocyte levels of proteasome and acyl-peptide hydrolase (APEH) activities in Alzheimer\u2019s disease: a sign of defective proteostasis? J Alzheimers Dis 60(3):1097\u20131106","journal-title":"J Alzheimers Dis"},{"key":"5624_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105797","volume":"114","author":"HD Nguyen","year":"2023","unstructured":"Nguyen HD, Kim YE, Nguyen LTN, Kwak IH, Lee YK, Kim YJ, Nguyen TTH, Pham HN et al (2023) Upregulation of immunoproteasome PSMB8 is associated with Parkinson\u2019s disease. Parkinsonism Relat Disord 114:105797","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"5624_CR13","doi-asserted-by":"publisher","first-page":"15765","DOI":"10.1038\/s41598-020-71550-5","volume":"10","author":"J Abi Habib","year":"2020","unstructured":"Abi Habib J, De Plaen E, Stroobant V, Zivkovic D, Bousquet M-P, Guillaume B, Wahni K, Messens J, et al (2020) Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins. Sci Rep 10(1):15765","journal-title":"Sci Rep"},{"issue":"2","key":"5624_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/pr.117.015370","volume":"71","author":"TA Thibaudeau","year":"2019","unstructured":"Thibaudeau TA, Smith DM (2019) A practical review of proteasome pharmacology. Pharmacol Rev 71(2):170\u2013197","journal-title":"Pharmacol Rev"},{"issue":"7","key":"5624_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/biomedicines10071591","volume":"10","author":"AA Covarrubias","year":"2022","unstructured":"Covarrubias AA, De la Fuente-Ortega E, Rossi G, Cocca E, Rossi M, Palmieri G, Pancetti FC (2022) Differential distribution and activity profile of acylpeptide hydrolase in the rat seminiferous epithelium. Biomedicines 10(7):1591","journal-title":"Biomedicines"},{"key":"5624_CR16","doi-asserted-by":"publisher","first-page":"109639","DOI":"10.1016\/j.cbi.2021.109639","volume":"348","author":"K Tyler","year":"2021","unstructured":"Tyler K, Geilman S, Bell DM, Taylor N, Honeycutt SC, Garrett PI, Hillhouse TM, Covey TM (2021) Acyl peptide enzyme hydrolase (APEH) activity is inhibited by lipid metabolites and peroxidation products. Chem Biol Interact 348:109639","journal-title":"Chem Biol Interact"},{"issue":"5968","key":"5624_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.1183147","volume":"327","author":"C-S Hwang","year":"2010","unstructured":"Hwang C-S, Shemorry A, Varshavsky A (2010) N-terminal acetylation of cellular proteins creates specific degradation signals. Science 327(5968):973\u2013977","journal-title":"Science"},{"issue":"15","key":"5624_CR18","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1093\/jxb\/eraf169","volume":"76","author":"SN Hoernstein","year":"2025","unstructured":"Hoernstein SN, Miniera AA, Reski R (2025) Acylamino acid-releasing enzyme, a bifunctional protease with a potential role in aging. J Exp Bot 76(15):4262\u20134278","journal-title":"J Exp Bot"},{"issue":"2","key":"5624_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1471-4159.2006.04251.x","volume":"100","author":"R Yamin","year":"2007","unstructured":"Yamin R, Bagchi S, Hildebrant R, Scaloni A, Widom RL, Abraham CR (2007) Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-\u03b2 peptide. J Neurochem 100(2):458\u2013467","journal-title":"J Neurochem"},{"issue":"1","key":"5624_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-4-33","volume":"4","author":"R Yamin","year":"2009","unstructured":"Yamin R, Zhao C, O\u2019Connor PB, McKee AC, Abraham CR (2009) Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. Mol Neurodegener 4(1):33","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5624_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ijms23010443","volume":"23","author":"A Sandomenico","year":"2021","unstructured":"Sandomenico A, Gogliettino M, Iaccarino E, Fusco C, Caporale A, Ruvo M, Palmieri G, Cocca E (2021) Oxidized substrates of APEH as a tool to study the endoprotease activity of the enzyme. Int J Mol Sci 23(1):443","journal-title":"Int J Mol Sci"},{"key":"5624_CR22","doi-asserted-by":"publisher","first-page":"1535310","DOI":"10.3389\/fnagi.2025.1535310","volume":"17","author":"X Lin","year":"2025","unstructured":"Lin X, Li Q, Pu M, Dong H, Zhang Q (2025) Significance of nicotine and nicotinic acetylcholine receptors in Parkinson\u2019s disease. Front Aging Neurosci 17:1535310","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5624_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2015.04.085","volume":"567","author":"MJ D\u00f6rfel","year":"2015","unstructured":"D\u00f6rfel MJ, Lyon GJ (2015) The biological functions of Naa10\u2014from amino-terminal acetylation to human disease. Gene 567(2):103\u2013131","journal-title":"Gene"},{"issue":"3","key":"5624_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1086\/500563","volume":"78","author":"JO Sass","year":"2006","unstructured":"Sass JO, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M, Loges NT, Schweitzer-Krantz S, et al (2006) Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet 78(3):401\u2013409","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5624_CR25","doi-asserted-by":"publisher","first-page":"C284","DOI":"10.1152\/ajpcell.00091.2016","volume":"311","author":"F Liebelt","year":"2016","unstructured":"Liebelt F, Vertegaal AC (2016) Ubiquitin-dependent and independent roles of SUMO in proteostasis. Am J Physiol Cell Physiol 311(2):C284\u2013C296","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"5624_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.embor.7400188","volume":"5","author":"PJ Kahle","year":"2004","unstructured":"Kahle PJ, Haass C (2004) How does parkin ligate ubiquitin to Parkinson\u2019s disease? First in molecular medicine review series. EMBO Rep 5(7):681\u2013685","journal-title":"EMBO Rep"},{"key":"5624_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105746","volume":"123","author":"IA Lambert-Smith","year":"2020","unstructured":"Lambert-Smith IA, Saunders DN, Yerbury JJ (2020) The pivotal role of ubiquitin-activating enzyme E1 (UBA1) in neuronal health and neurodegeneration. Int J Biochem Cell Biol 123:105746","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"5624_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molmed.2015.08.003","volume":"21","author":"EJ Groen","year":"2015","unstructured":"Groen EJ, Gillingwater TH (2015) UBA1: at the crossroads of ubiquitin homeostasis and neurodegeneration. Trends Mol Med 21(10):622\u2013632","journal-title":"Trends Mol Med"},{"issue":"2","key":"5624_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.embor.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5(2):213\u2013218","journal-title":"EMBO Rep"},{"issue":"1","key":"5624_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jfma.2020.06.023","volume":"120","author":"Y-R Wu","year":"2021","unstructured":"Wu Y-R, Chang K-H, Chao C-Y, Lin C-H, Chen Y-C, Liu T-W, Lee-Chen G-J, Chen C-M (2021) Association of SOD2 p. V16A polymorphism with Parkinson\u2019s disease: a meta-analysis in Han Chinese. J Formos Med Assoc 120(1):501\u2013507","journal-title":"J Formos Med Assoc"},{"key":"5624_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.05.027","volume":"62","author":"JM Flynn","year":"2013","unstructured":"Flynn JM, Melov S (2013) SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic Biol Med 62:4\u201312","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"5624_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/cells14120863","volume":"14","author":"ZQ Yang","year":"2025","unstructured":"Yang ZQ, Campeanu IJ, Lopez I, Syed M, Jiang Y, Afisllari H (2025) NAA10 (N-alpha-acetyltransferase 10): a multifunctional regulator in development, disease, and cancer. Cells 14(12):863","journal-title":"Cells"},{"issue":"2","key":"5624_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","volume":"124","author":"D Ebrahimi-Fakhari","year":"2012","unstructured":"Ebrahimi-Fakhari D, Wahlster L, McLean PJ (2012) Protein degradation pathways in Parkinson\u2019s disease: curse or blessing. Acta Neuropathol 124(2):153\u2013172","journal-title":"Acta Neuropathol"},{"issue":"27","key":"5624_CR34","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1021\/acs.jpcb.0c04435","volume":"124","author":"A Saha","year":"2020","unstructured":"Saha A, Oanca G, Mondal D, Warshel A (2020) Exploring the proteolysis mechanism of the proteasomes. J Phys Chem B 124(27):5626\u20135635","journal-title":"J Phys Chem B"},{"issue":"9","key":"5624_CR35","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3390\/cancers12092385","volume":"12","author":"C Brancolini","year":"2020","unstructured":"Brancolini C, Iuliano L (2020) Proteotoxic stress and cell death in cancer cells. Cancers (Basel) 12(9):2385","journal-title":"Cancers (Basel)"},{"issue":"3","key":"5624_CR36","doi-asserted-by":"publisher","DOI":"10.4110\/in.2022.22.e28","volume":"22","author":"S Kim","year":"2022","unstructured":"Kim S, Park SH, Choi WH, Lee MJ (2022) Evaluation of immunoproteasome-specific proteolytic activity using fluorogenic peptide substrates. Immune Netw 22(3):e28","journal-title":"Immune Netw"},{"key":"5624_CR37","doi-asserted-by":"crossref","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC. Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta neuropathologica. 2014 Nov;128(5):651-63.","DOI":"10.1007\/s00401-014-1345-4"},{"issue":"5","key":"5624_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13022","volume":"93","author":"M \u00d6berg","year":"2021","unstructured":"\u00d6berg M, Fabrik I, Fabrikova D, Zehetner N, H\u00e4rtlova A (2021) The role of innate immunity and inflammation in Parkinson s disease. Scand J Immunol 93(5):e13022","journal-title":"Scand J Immunol"},{"issue":"2","key":"5624_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/ijerph6020445","volume":"6","author":"A Valavanidis","year":"2009","unstructured":"Valavanidis A, Vlachogianni T, Fiotakis K (2009) Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6(2):445\u2013462","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"5624_CR40","doi-asserted-by":"publisher","first-page":"L814","DOI":"10.1152\/ajplung.00128.2012","volume":"303","author":"SH van Rijt","year":"2012","unstructured":"van Rijt SH, Keller IE, John G, Kohse K, Yildirim A\u00d6, Eickelberg O, Meiners S (2012) Acute cigarette smoke exposure impairs proteasome function in the lung. Am J Physiol-Lung Cellu Molecul Physiol 303(9):L814\u2013L823","journal-title":"Am J Physiol-Lung Cellu Molecul Physiol"},{"issue":"1","key":"5624_CR41","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1038\/s41467-021-26427-0","volume":"12","author":"I Sahu","year":"2021","unstructured":"Sahu I, Mali SM, Sulkshane P, Xu C, Rozenberg A, Morag R, Sahoo MP, Singh SK, et al (2021) The 20S as a stand-alone proteasome in cells can degrade the ubiquitin tag. Nat Commun 12(1):6173","journal-title":"Nat Commun"},{"key":"5624_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mam.2016.05.001","volume":"50","author":"R Raynes","year":"2016","unstructured":"Raynes R, Pomatto LC, Davies KJ (2016) Degradation of oxidized proteins by the proteasome: distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Mol Aspects Med 50:41\u201355","journal-title":"Mol Aspects Med"},{"issue":"12","key":"5624_CR43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/14728222.2022.2166828","volume":"26","author":"C Chen","year":"2022","unstructured":"Chen C, Hertz E, Chen Y, Sidransky E (2022) Targeting protein clearance pathways in GBA1-associated Parkinson disease. Expert Opin Ther Targets 26(12):1031\u20131035","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"5624_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-160921","volume":"7","author":"E Bentea","year":"2017","unstructured":"Bentea E, Verbruggen L, Massie A (2017) The proteasome inhibition model of Parkinson\u2019s disease. J Parkinsons Dis 7(1):31\u201363","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"5624_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.wnl.0000198511.09968.b3","volume":"66","author":"F Blandini","year":"2006","unstructured":"Blandini F, Sinforiani E, Pacchetti C, Samuele A, Bazzini E, Zangaglia R, Nappi G, Martignoni E (2006) Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 66(4):529\u2013534","journal-title":"Neurology"},{"issue":"2","key":"5624_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1523\/JNEUROSCI.1541-11.2012","volume":"32","author":"A Berthet","year":"2012","unstructured":"Berthet A, Bezard E, Porras G, Fasano S, Barroso-Chinea P, Dehay B, Martinez A, Thiolat M-L, et al (2012) L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci 32(2):681\u2013691","journal-title":"J Neurosci"},{"issue":"2","key":"5624_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5114\/fn.2013.35955","volume":"51","author":"A Hurny","year":"2013","unstructured":"Hurny A, Micha\u0142owska-Wender G, Wender M (2013) Impact of L-DOPA treatment of patients with Parkinson\u2019s disease on mononuclear subsets and phagocytosis in the peripheral blood. Folia Neuropathol 51(2):127\u2013131","journal-title":"Folia Neuropathol"},{"issue":"11","key":"5624_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020362","volume":"2","author":"S Shendelman","year":"2004","unstructured":"Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits \u03b1-synuclein aggregate formation. PLoS Biol 2(11):e362","journal-title":"PLoS Biol"},{"issue":"1","key":"5624_CR49","doi-asserted-by":"publisher","first-page":"30793","DOI":"10.1038\/srep30793","volume":"6","author":"Y Saito","year":"2016","unstructured":"Saito Y, Akazawa-Ogawa Y, Matsumura A, Saigoh K, Itoh S, Sutou K, Kobayashi M, Mita Y, et al (2016) Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson\u2019s disease patients. Sci Rep 6(1):30793","journal-title":"Sci Rep"},{"key":"5624_CR50","doi-asserted-by":"publisher","first-page":"1531797","DOI":"10.3389\/fcell.2024.1531797","volume":"12","author":"TR Church","year":"2025","unstructured":"Church TR, Margolis SS (2025) Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease. Front Cell Dev Biol 12:1531797","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"5624_CR51","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1111\/febs.17114","volume":"291","author":"S Al Rawi","year":"2024","unstructured":"Al Rawi S, Simpson L, Agnarsd\u00f3ttir G, McDonald NQ, Chernuha V, Elpeleg O, Zeviani M, Barker RA, et al (2024) Study of an FBXO7 patient mutation reveals Fbxo7 and PI 31 co-regulate proteasomes and mitochondria. FEBS J 291(12):2565\u20132589","journal-title":"FEBS J"},{"issue":"1","key":"5624_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13578-022-00831-5","volume":"12","author":"N D\u2019Ascenzo","year":"2022","unstructured":"D\u2019Ascenzo N, Antonecchia E, Angiolillo A, Bender V, Camerlenghi M, Xie Q, Di Costanzo A (2022) Metabolomics of blood reveals age-dependent pathways in Parkinson\u2019s disease. Cell Biosci 12(1):102","journal-title":"Cell Biosci"},{"issue":"1","key":"5624_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00732-z","volume":"10","author":"X Luo","year":"2024","unstructured":"Luo X, Liu Y, Balck A, Klein C, Fleming RM (2024) Identification of metabolites reproducibly associated with Parkinson\u2019s disease via meta-analysis and computational modelling. NPJ Parkinsons Dis 10(1):126","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5624_CR54","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41598-017-06767-y","volume":"7","author":"S Saiki","year":"2017","unstructured":"Saiki S, Hatano T, Fujimaki M, Ishikawa K-I, Mori A, Oji Y, Okuzumi A, Fukuhara T, et al (2017) Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for Parkinson\u2019s disease. Sci Rep 7(1):7328","journal-title":"Sci Rep"},{"key":"5624_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115094","volume":"165","author":"G Ferretti","year":"2023","unstructured":"Ferretti G, Serafini S, Angiolillo A, Monterosso P, Di Costanzo A, Matrone C (2023) Advances in peripheral blood biomarkers of patients with Alzheimer\u2019s disease: moving closer to personalized therapies. Biomed Pharmacother 165:115094","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"5624_CR56","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1177\/0271678X251340513","volume":"45","author":"S Serafini","year":"2025","unstructured":"Serafini S, Angiolillo A, Ferretti G, Viviani G, Matrone C, Di Costanzo A (2025) Exploring differences in circulating metabolites of females and males with Alzheimer\u2019s disease. J Cereb Blood Flow Metab 45(10):2004\u20132015","journal-title":"J Cereb Blood Flow Metab"},{"key":"5624_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117629","volume":"551","author":"EA Jennings","year":"2023","unstructured":"Jennings EA, Abi-Rached ZH, Jones DE, Ryan RO (2023) 3-methylglutarylcarnitine: a biomarker of mitochondrial dysfunction. Clin Chim Acta 551:117629","journal-title":"Clin Chim Acta"},{"key":"5624_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/978-1-4419-6741-1_6","volume":"688","author":"MN Nikolova-Karakashian","year":"2010","unstructured":"Nikolova-Karakashian MN, Rozenova KA (2010) Ceramide in stress response. Sphingolipids Signal Regulat Molecul 688:86\u2013108","journal-title":"Sphingolipids Signal Regulat Molecul"},{"issue":"6","key":"5624_CR59","first-page":"1351","volume":"110","author":"RT Bishop","year":"2024","unstructured":"Bishop RT, Li T, Sudalagunta PR, Nasr MM, Nyman KJ, Alugubelli RR, Meads MB, Frieling JS, et al (2024) Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed\/refractory multiple myeloma. Haematologica 110(6):1351","journal-title":"Haematologica"},{"issue":"7","key":"5624_CR60","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101(7):2070\u20132075","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5624_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19(3):175\u2013191","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"50","key":"5624_CR62","doi-asserted-by":"publisher","first-page":"38841","DOI":"10.1074\/jbc.M110.127993","volume":"285","author":"C Loveridge","year":"2010","unstructured":"Loveridge C, Tonelli F, Leclercq T, Lim KG, Long JS, Berdyshev E, Tate RJ, Natarajan V, et al (2010) The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells. J Biol Chem 285(50):38841\u201338852","journal-title":"J Biol Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05624-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:03:30Z","timestamp":1766556210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05624-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5624"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05624-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"326"}}